Optimising the body's immune response with a Nanopatch that delivers biomolecules to the skin

该团队正在开发一种新的改进方法来接种疫苗，以预防流感和疟疾等致命传染病。他们相信，他们的纳米贴片技术将增强季节性流感疫苗的效力，甚至可以解决流感大流行期间的疫苗短缺问题。这是因为纳米贴片比传统注射器需要的疫苗少得多。他们还预测，与传统疫苗相比，用纳米贴片递送的疫苗需要更少的冷藏，并且可以由没有接受过医疗培训的个人安全接种，从而使更多人以更低的成本获得疫苗接种的好处，甚至在偏远地区也是如此。

The team is developing a new improved way to vaccinate against deadly infectious diseases such as influenza and malaria. They believe their Nanopatch technology will boost the power of seasonal influenza vaccination and could even solve vaccine shortages in an influenza pandemic. This is because the Nanopatch needs much less vaccine per person than a conventional syringe. They also predict that vaccines delivered with a Nanopatch will require less refrigeration than conventional vaccines and can be safely administered by individuals without medical training, making the benefits of vaccination accessible to more people more cheaply, even in remote areas.